Xtx Topco LTD Adc Therapeutics Sa Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Xtx Topco LTD holds 115,073 shares of ADCT stock, worth $228,995. This represents 0.03% of its overall portfolio holdings.
Number of Shares
115,073
Previous 56,863
102.37%
Holding current value
$228,995
Previous $179,000
102.23%
% of portfolio
0.03%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding ADCT
# of Institutions
80Shares Held
55.1MCall Options Held
82.7KPut Options Held
31.5K-
Redmile Group, LLC San Francisco, CA15.7MShares$31.2 Million3.23% of portfolio
-
Prosight Management, LP Dallas, TX9.64MShares$19.2 Million8.15% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.53MShares$9.02 Million0.34% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$7.07 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$6.05 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $155M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...